Docencia
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial
Dra. Joana Vitalle Andrade
Instituto de Biomedicinade Sevilla(IBiS)
Hospital Universitario Virgen del Rocio
Efficacy, safety, and tolerabilityof switchingto long-actingcabotegravirplus rilpivirineversus continuingfixed-dosebictegravir, emtricitabine…
Dr. Javier García Abellán
Unidad de Enfermedades Infecciosa
Hospital General Universitario de Elche
Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study (23/06/2023)
Dr. Oskar Ayerdi Aguirrebengoa
Centro Sanitario Sandoval, IdISSC.
Hospital Clínico San Carlos, Madrid.
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial (09/06/2023)
Dra. Verónica Briz
Centro Nacional de Microbiología Instituto de Salud Carlos III.
Effects of clinical, comorbid, and social determinants of health on brain ageing in people with and without HIV: a retrospective case-control study (26/05/2023)
Dra. Isabel A. Pérez Hernández
Unidad de Enfermedades Infecciosas.
Hospital Universitario Virgen de la Victoria, Málaga.
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections (12/05/2023)
Dr. Boris Revollo B.
MD, PhD Germans Trias i Pujol University Hospital.
Infectious Diseases Department.
Fight Infections Foundation.
Early antirretroviral therapy not associated with higher cryptococcal meningitis mortality in people with HIV in high income countries : an international collaborative cohort study (28/04/2023)
Dra. Helena Albendín Iglesias
Hospital Clínico Universitario Virgen de la Arrixaca.
Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens (14/04/2023)
Dra. Miriam Estébanez Muñoz
Hospital Universitario “Gómez Ulla”, Madrid.
Sección Enfermedades Infecciosas, Medicina Interna.
Mpox in people with advanced HIV infection: a global case series (31/03/2023)
Dr. Oskar Ayerdi Aguirrebengoa
Centro Sanitario Sandoval, IdISSC.
Hospital Clínico San Carlos, Madrid.
Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial (17/03/2023)
Dra. Verónica Briz
Centro Nacional de Microbiología Instituto de Salud Carlos III.
Increasing HIV early diagnosis by implementing an automated screening strategy in emergency departments (03/03/2023)
Dra. Isabel A. Pérez Hernández
Unidad de Enfermedades Infecciosas.
Hospital Universitario Virgen de la Victoria, Málaga.
Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort (17/02/2023)
Dr. Boris Revollo B.
MD, PhD Germans Trias i Pujol University Hospital.
Infectious Diseases Department.
Fight Infections Foundation.
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort (20/01/2023)
Dra. Miriam Estébanez Muñoz
Hospital Universitario “Gómez Ulla”, Madrid.
Sección Enfermedades Infecciosas, Medicina Interna.
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study (09/01/2023)
Dr. Oskar Ayerdi Aguirrebengoa
Centro Sanitario Sandoval, IdISSC.
Hospital Clínico San Carlos, Madrid.
Stable Latent HIV Infection and Low level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat (09/12/2022)
Dra. Verónica Briz
Centro Nacional de Microbiología.
Instituto de Salud Carlos III.
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention (25/11/2022)
Dra. Isabel A. Pérez Hernández
Unidad de Enfermedades Infecciosas
Hospital Universitario Virgen de la Victoria, Málaga.
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer (11/11/2022)
Dr. Boris Revollo
Germans Trias i Pujol University Hospital.
Infectious Diseases Department. Fight Infections Foundation.
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium (28/10/2022)
Helena Albendín Iglesias
Hospital Clínico Universitario Virgen de la Arrixaca.
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection (14/10/2022)
Dra. Miriam Estébanez Muñoz
Sección Enfermedades Infecciosas.
Medicina Interna Hospital Universitario “Gómez Ulla”, Madrid.
